Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenny Roose

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
The Journal of General Virology|October 23, 2010
Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotectiveMarina De Filette, Tine Ysenbaert, Kenny Roose, et al.
The Journal of Biological Chemistry|February 7, 2008
An influenza A vaccine based on tetrameric ectodomain of matrix protein 2Marina De Filette, Wouter Martens, Kenny Roose, et al.
Molecular Therapy. Nucleic Acids|November 24, 2020
The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of AdministrationLien Van Hoecke, Kenny Roose, Marlies Ballegeer, et al.
Antiviral Research|March 5, 2017
Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infectionJochen Pendzialek, Kenny Roose, Anouk Smet, et al.
Plos One|May 15, 2015
Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli PhagesLei Deng, Lorena Itatí Ibañez, Veronique Van den Bossche, et al.
Nature Communications|August 26, 2018
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopesLien Van Hoecke, Sandra Van Lint, Kenny Roose, et al.
The Journal of Biological Chemistry|November 14, 2014
Sequence-dependent internalization of aggregating peptidesJosé R Couceiro, Rodrigo Gallardo, Frederik De Smet, et al.
Mbio|July 13, 2021
<i>In Vivo</i> Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 ExpressionSilvie Van den Hoecke, Marlies Ballegeer, Bram Vrancken, et al.
Nature Communications|July 2, 2025
Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B virusesArne Matthys, Jan Felix, Joao Paulo Portela Catani, et al.
Plos One|March 28, 2015
A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibodySarah De Baets, Judith Verhelst, Silvie Van den Hoecke, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The Journal of General Virology|October 23, 2010
Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotectiveMarina De Filette, Tine Ysenbaert, Kenny Roose, et al.
The Journal of Biological Chemistry|February 7, 2008
An influenza A vaccine based on tetrameric ectodomain of matrix protein 2Marina De Filette, Wouter Martens, Kenny Roose, et al.
Molecular Therapy. Nucleic Acids|November 24, 2020
The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of AdministrationLien Van Hoecke, Kenny Roose, Marlies Ballegeer, et al.
Antiviral Research|March 5, 2017
Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infectionJochen Pendzialek, Kenny Roose, Anouk Smet, et al.
Plos One|May 15, 2015
Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli PhagesLei Deng, Lorena Itatí Ibañez, Veronique Van den Bossche, et al.
Nature Communications|August 26, 2018
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopesLien Van Hoecke, Sandra Van Lint, Kenny Roose, et al.
The Journal of Biological Chemistry|November 14, 2014
Sequence-dependent internalization of aggregating peptidesJosé R Couceiro, Rodrigo Gallardo, Frederik De Smet, et al.
Mbio|July 13, 2021
<i>In Vivo</i> Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 ExpressionSilvie Van den Hoecke, Marlies Ballegeer, Bram Vrancken, et al.
Nature Communications|July 2, 2025
Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B virusesArne Matthys, Jan Felix, Joao Paulo Portela Catani, et al.
Plos One|March 28, 2015
A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibodySarah De Baets, Judith Verhelst, Silvie Van den Hoecke, et al.
Pageof 4